Accelerated healing in NONcNZO10/LtJ type 2 diabetic mice by FGF-1

Wound Repair and Regeneration

Volumn 23, Issue 4, 2015, Pages 538-549

  Blaber, Sachiko I ^a   Diaz, Jose ^a   Blaber, Michael ^a  

^a FLORIDA STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

diabetic ulcer; fibroblast growth factor 1; growth factor; Protein engineering; protein stability

Indexed keywords

FIBROBLAST GROWTH FACTOR 1; HEPARIN; DRUG COMBINATION; MUTANT PROTEIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLUMN CHROMATOGRAPHY; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG COST; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG FORMULATION; DRUG MEGADOSE; DRUG SAFETY; EPITHELIZATION; FEMALE; HISTOLOGY; LIMIT OF QUANTITATION; MALE; MEAN RESIDENCE TIME; MITOGENESIS; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ENGINEERING; PUNCH BIOPSY; QUANTITATIVE ANALYSIS; SIZE EXCLUSION CHROMATOGRAPHY; WILD TYPE; WOUND ASSESSMENT; WOUND HEALING; ANIMAL; CHRONIC DISEASE; COMPLICATION; DRUG COMBINATION; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; PATHOLOGY; PHYSIOLOGY; SKIN; SKIN ULCER; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ANIMALS; CHRONIC DISEASE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DRUG COMBINATIONS; FIBROBLAST GROWTH FACTOR 1; HEPARIN; MALE; MICE; MUTANT PROTEINS; RE-EPITHELIALIZATION; SKIN; SKIN ULCER; TREATMENT OUTCOME; WOUND HEALING;

EID: 84940718209     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/wrr.12305     Document Type: Article

References (34)

1. Boyle JP, Thompson TJ, Gregg EW, Barker LE, Williamson DF,. Projection of the year 2050 burden of diabetes in the US adult population: Dynamic modeling of incidence, mortality, and prediabetes prevalence. Population Health Metrics 2010; 8: 29.
2. Adler AI, Boyko EJ, Ahroni JH, Smith DG,. Lower-extremity amputation in diabetes. The independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers. Diabetes Care 1999; 22: 1029-35.
3. Lepow BD, Downey M, Yurgelon J, Klassen L, Armstrong DG,. Bioengineered tissues in wound healing-A progress report. Expert Rev Dermatol 2011; 6: 255-62.
4. Kranke P, Bennett MH, Martyn-St James M, Schnabel A, Debus SE., Hyperbaric oxygen therapy for chronic wounds. Cochrane Database of Syst Rev 2012; 4: CD004123.
5. Ubbink DT, Westerbos SJ, Evans D, Land L, Vermeulen H,. Topical negative pressure for treating chronic wounds. Cochrane Database of Syst Rev 2008; 3: CD001898.
6. Brown RL, Breeden MP, Greenhalgh DG,. PDGF and TGF - A act synergistically to improve wound healing in the genetically diabetic mouse. J Surg Res 1994; 56: 562-70.
7. Matuszewska B, Keogan M, Fisher DM, Soper KA, Hoe C-M, Huber AC, et al., Acidic fibroblast growth factor: Evaluation of topical formulations in a diabetic mouse wound healing model. Pharm Res 1994; 11: 65-71.
8. Mellin TN, Cashen DE, Ronan JJ, Murphy BS, DiSalvo J, Thomas KA,. Acidic fibroblast growth factor accelerates dermal wound healing in diabetic mice. J Invest Dermatol 1995; 104: 850-5.
9. Tan Y, Xiao J, Huang Z, Xiao Y, Lin S, Jin L, et al., Comparison of the therapeutic effects of recombinant human acidic and basic fibroblast growth factors in wound healing in diabetic patients. J Health Sci 2008; 54: 432-40.
10. Wang W, Lin S, Xiao Y, Huang Y, Tan Y, Cai L, et al., Acceleration of diabetic wound healing with chitosan-crosslinked collagen sponge containing recombinant human acidic fibroblast growth factor in healing-impaired STZ diabetic rats. Life Sci 2008; 82: 190-204.
11. Blumberg SN, Berger A, Hwang L, Pastar I, Warren SM, Chen W,. The role of stem cells in the treatment of diabetic foot ulcers. Diabetes Res Clin Pract 2012; 96: 1-9.
12. Shipley GD, Keeble WW, Hendrickson JE, Coffey RJ, Jr., Pittelkow MR,. Growth of normal human keratinocytes and fibroblasts in serum-free medium is stimulated by acidic and basic fibroblast growth factor. J Cell Physiol 1989; 138: 511-8.
13. Thomas KA, Rios-Candelore M, Gimenez-Gallego G, DiSalvo J, Bennett C, Rodkey J, et al., Pure brain-derived acidic fibroblast growth factor is a potent angiogenic vascular endothelial cell mitogen with sequence homology to interleukin 1. Proc Natl Acad Sci USA 1985; 82: 6409-13.
14. Rozengurt E,. The mitogenic response of cultured 3T3 cells: Integration of early signals and synergistic effects in a unified framework. Amsterdam: Elsevier, 1985.
15. Mellin TN, Mennie RJ, Cashen DE, Ronan JJ, Capparella J, James ML, et al., Acidic fibroblast growth factor accelerates dermal wound healing. Growth Factors 1992; 7: 1-14.
16. Baker M,. Why hES cells make teratomas. Nat Rep Stem Cells 2009 Mar 5. doi: 10.1038/stemcells.2009.36.
17. Ma B, Da-Sheng C, Zhao-Fan X, Dao-Feng B, Wei L, Zhi-Fang C, et al., Randomized, multicenter, double-blind, and placebo-controlled trial using topical recombinant human acidic fibroblast growth factor for deep partial-thickness burns and skin graft donor site. Wound Repair Regen 2007; 15: 795-9.
18. Ioli V, Wiens B, Mellin T, Thomas K, Ellis R, Ryan J, White CJ,. Effect of topically applied acidic fibroblast growth factor (FGF-1) on healing of chronic venous stasis and diabetic ulcers. Abstracts of the 5th Annual Symposium on Advanced Wound Care, 1992: 150.
19. Copeland RA, Ji H, Halfpenny AJ, Williams RW, Thompson KC, Herber WK, et al., The structure of human acidic fibroblast growth factor and its interaction with heparin. Arch Biochem Biophys 1991; 289: 53-61.
20. Prechel M, Walenga JM,. Heparin-induced thrombocytopenia: An update. Semin Thromb Hemost 2012; 38: 483-96.
21. Cho YR, Kim HJ, Park SY, Ko HJ, Hong EG, Higashimori T, et al., Hyperglycemia, maturity-onset obesity, and insulin resistance in NONcNZO10/LtJ males, a new mouse model of type 2 diabetes. Am J Physiol Endocrinol Metab 2007; 293: E327-E36.
22. Fang RC, Kryger ZB, Buck DWI, De La Garza M, Galiano RD, Mustoe TA,. Limitations of the db/db mouse in translational wound healing research: Is the NONcNZO10 polygenic mouse model superior? Wound Repair Regen 2010; 18: 605-13.
23. Galiano RD, Michaels Jt, Dobryansky M, Levine JP, Gurtner GC,. Quantitative and reproducible murine model of excisional wound healing. Wound Repair Regen 2004; 12: 485-92.
24. Davidson JM, Yu F, Opalenik SR,. Splinting strategies to overcome confounding wound contraction in experimental animal models. Adv Wound Care 2013; 2: 142-8.
25. Xia X, Babcock JP, Blaber SI, Harper KM, Blaber M,. Pharmacokinetic properties of 2nd-generation fibroblast growth factor-1 mutants for therapeutic application. PLoS One 2012; 7: e48210.
26. Gimenez-Gallego G, Conn G, Hatcher VB, Thomas KA,. The complete amino acid sequence of human brain-derived acidic fibroblast growth factor. Biochem Biophys Res Commun 1986; 128: 611-7.
27. Blaber SI, Culajay JF, Khurana A, Blaber M,. Reversible thermal denaturation of human FGF-1 induced by low concentrations of guanidine hydrochloride. Biophys J 1999; 77: 470-7.
28. Dubey VK, Lee J, Somasundaram T, Blaber S, Blaber M,. Spackling the crack: Stabilizing human fibroblast growth factor-1 by targeting the N and C terminus beta-strand interactions. J Mol Biol 2007; 371: 256-68.
29. Tsai PK, Volkin DB, Dabora JM, Thompson KC, Bruner MW, Gress JO, et al., Formulation design of acidic fibroblast growth factor. Pharm Res 1993; 10: 649-59.
30. Zazo M, Lozano RM, Ortega S, Varela J, Diaz-Orejas R, Ramirez JM, et al., High-level synthesis in Escherichia coli of a shortened and full-length human acidic fibroblast growth factor and purification in a form stable in aqueous solutions. Gene 1992; 113: 231-8.
31. Gill SC, von Hippel PH,. Calculation of protein extinction coefficients from amino acid sequence data. Anal Biochem 1989; 182: 319-26.
32. Abramoff MD, Magalhaes PJ, Ram SJ,. Image Processing with ImageJ. Biophotonics Int 2004; 11: 36-42.
33. Buck DWI, Jin DP, Geringer M, Hong SJ, Galiano RD, Mustoe TA,. The TallyHo polygenic mouse model of diabetes: Implications in wound healing. Plastic Reconstr Surg 2011; 128: 427e-37e.
34. Michaels J, Churgin SS, Blechman KM, Greives MR, Aarabi S, Galiano RD, et al., db/db mice exhibit severe wound-healing impairments compared with other murine diabetic strains in a silicone-splinted excisional wound model. Wound Repair Regen 2007; 15: 665-70.